Literature DB >> 12952261

Myopathological features in skeletal muscle of patients with chronic obstructive pulmonary disease.

H R Gosker1, B Kubat, G Schaart, G J van der Vusse, E F M Wouters, A M W J Schols.   

Abstract

Despite the fact that muscle weakness is a major problem in chronic obstructive pulmonary disease (COPD), detailed information on myopathological changes at the microscopic level in these patients is scarce, if indeed available at all. Vastus lateralis biopsies of 15 COPD weight-stable patients (body mass index (BMI) 23.9+/-1.0 kg x m(-2); fat-free mass index (FFMI) 17.2+/-1.7 kg x m(-2)) and 16 healthy age-matched controls (BMI 26.3+/-0.8 kg x m(-2); FFMI 19.6+/-2.2 kg x m(-2)) were evaluated. Histochemistry was used to evaluate myopathological features. Immunohistochemistry was used for the detection of macrophages and leukocytes, and active caspase 3 and terminal deoxynucleotidyl transferase deoxyuridine triphosphate (dUTP) nick-end labelling (TUNEL) as markers of apoptosis. Fatty cell replacement and fibrosis were observed in both groups, the latter being slightly, but significantly, more pronounced in COPD. No differences between COPD and controls were found with respect to central nuclei, necrosis, regeneration, or fibre splitting. Signs of mitochondrial abnormalities were absent and normal numbers of inflammatory cells were found. Active caspase 3 positive myocytes were not observed and no difference was found in the number of TUNEL-positive myonuclei between controls and COPD patients (1.1% versus 1.0%, respectively). The cross-sectional area of type-IIX muscle fibres was smaller in COPD than in controls (2,566 versus 4,248 microm2). Except for the I to IIX shift in fibre types, the selective type-IIX atrophy and a slight accompanying increase in fibrosis and fat cell replacement in chronic obstructive pulmonary disease relative to age-matched controls, no other morphological abnormalities were observed in the muscle biopsies of chronic obstructive pulmonary disease patients. Also, in this group of clinically and weight stable chronic obstructive pulmonary disease patients, apoptosis appeared not to be involved in muscle pathology.

Entities:  

Mesh:

Year:  2003        PMID: 12952261     DOI: 10.1183/09031936.03.00012803

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  32 in total

Review 1.  Preservation of eccentric strength in older adults: Evidence, mechanisms and implications for training and rehabilitation.

Authors:  Marc Roig; Donna L Macintyre; Janice J Eng; Marco V Narici; Constantinos N Maganaris; W Darlene Reid
Journal:  Exp Gerontol       Date:  2010-03-18       Impact factor: 4.032

Review 2.  Molecular and biological pathways of skeletal muscle dysfunction in chronic obstructive pulmonary disease.

Authors:  Esther Barreiro; Joaquim Gea
Journal:  Chron Respir Dis       Date:  2016-04-06       Impact factor: 2.444

3.  Compression garments to prevent delayed onset muscle soreness in soccer players.

Authors:  Xavier Valle; Lluís Til; Franchek Drobnic; Antonio Turmo; José Bruno Montoro; Oliver Valero; Rosa Artells
Journal:  Muscles Ligaments Tendons J       Date:  2014-02-24

4.  Microbiopsies versus Bergström needle for skeletal muscle sampling: impact on maximal mitochondrial respiration rate.

Authors:  M E Isner-Horobeti; A Charton; F Daussin; B Geny; S P Dufour; R Richard
Journal:  Eur J Appl Physiol       Date:  2014-01-22       Impact factor: 3.078

5.  Regional skeletal muscle remodeling and mitochondrial dysfunction in right ventricular heart failure.

Authors:  Rob C I Wüst; David S Myers; Rachel Stones; David Benoist; Philip A Robinson; John P Boyle; Chris Peers; Ed White; Harry B Rossiter
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-10-28       Impact factor: 4.733

Review 6.  Muscle dysfunction in chronic obstructive pulmonary disease: update on causes and biological findings.

Authors:  Joaquim Gea; Sergi Pascual; Carme Casadevall; Mauricio Orozco-Levi; Esther Barreiro
Journal:  J Thorac Dis       Date:  2015-10       Impact factor: 2.895

Review 7.  An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease.

Authors:  François Maltais; Marc Decramer; Richard Casaburi; Esther Barreiro; Yan Burelle; Richard Debigaré; P N Richard Dekhuijzen; Frits Franssen; Ghislaine Gayan-Ramirez; Joaquim Gea; Harry R Gosker; Rik Gosselink; Maurice Hayot; Sabah N A Hussain; Wim Janssens; Micheal I Polkey; Josep Roca; Didier Saey; Annemie M W J Schols; Martijn A Spruit; Michael Steiner; Tanja Taivassalo; Thierry Troosters; Ioannis Vogiatzis; Peter D Wagner
Journal:  Am J Respir Crit Care Med       Date:  2014-05-01       Impact factor: 21.405

8.  Angiogenesis-related factors in skeletal muscles of COPD patients: roles of angiopoietin-2.

Authors:  Mahroo Mofarrahi; Ioanna Sigala; Theodoros Vassilokopoulos; Sharon Harel; Yeting Guo; Richard Debigare; Francois Maltais; Sabah N A Hussain
Journal:  J Appl Physiol (1985)       Date:  2013-01-10

Review 9.  Factors contributing to muscle wasting and dysfunction in COPD patients.

Authors:  Rob C I Wüst; Hans Degens
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007

Review 10.  Apoptotic mechanisms in the pathogenesis of COPD.

Authors:  Maria Plataki; Eleni Tzortzaki; Paula Rytila; Makris Demosthenes; Anastassios Koutsopoulos; Nikolaos M Siafakas
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.